- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4162 - 1,2-Diazoles condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/4162
Total number of patents in this class: 1210
10-year publication summary
|
64
|
84
|
77
|
76
|
93
|
100
|
92
|
106
|
58
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10341 |
34 |
| Merck Sharp & Dohme LLC | 3732 |
30 |
| Achillion Pharmaceuticals, Inc. | 159 |
25 |
| Bayer AG | 3455 |
20 |
| The Broad Institute, Inc. | 1944 |
17 |
| Boehringer Ingelheim International GmbH | 4496 |
16 |
| Merck Sharp & Dohme Corp. | 2184 |
15 |
| Bayer Pharma AG | 1025 |
15 |
| Dana-Farber Cancer Institute, Inc. | 2654 |
15 |
| Vertex Pharmaceuticals Incorporated | 1595 |
14 |
| Janssen Pharmaceutica N.V. | 3226 |
13 |
| Warsaw Orthopedic, Inc. | 2810 |
13 |
| F. Hoffmann-La Roche AG | 7841 |
12 |
| Array BioPharma Inc. | 458 |
12 |
| The Regents of the University of California | 20587 |
11 |
| Merck Patent GmbH | 5669 |
11 |
| Nerviano Medical Sciences S.r.l. | 238 |
11 |
| The Trustees of the University of Pennsylvania | 4406 |
9 |
| Takeda Pharmaceutical Company Limited | 2716 |
9 |
| Omeros Corporation | 304 |
9 |
| Other owners | 899 |